ID

31890

Descripción

Topical Itraconazole in the Treatment of Basal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02120677

Link

https://clinicaltrials.gov/show/NCT02120677

Palabras clave

Versiones (1)
  1. 7/10/18 7/10/18 -
Titular de derechos de autor

Johns Hopkins University

Subido en

7 de octubre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Basal Cell Carcinoma NCT02120677

Inglés

Eligibility Basal Cell Carcinoma NCT02120677

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
participants must be over the age of 18 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
male
Descripción

Male

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1706180
women who do not have child-bearing potential (history of hysterectomy, post-menopausal)
Descripción

Women without child-bearing potential

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0332268
have a biopsy confirmed bcc that measures at least 6mm in size at the time of the initial evaluation (visit #1);
Descripción

Biopsy confirmed bcc

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007117
UMLS CUI [1,2]
C0005558
UMLS CUI [2]
C0449453
participant must be willing and comply with the requirements of the protocol;
Descripción

Protocol Compliance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0525058
participant must have the ability to understand and communicate with the investigator;
Descripción

Able to understand and communicate

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2364293
UMLS CUI [2]
C0162340
participant must provide informed consent.
Descripción

Informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
subject with significant congestive heart failure (chf) or history of chf, chronic renal failure, hepatic failure, neuropathy
Descripción

History of Congestive heart failure, chronic renal failure, hepatic failure, neuropathy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C0521116
UMLS CUI [2,1]
C0018802
UMLS CUI [2,2]
C0262926
UMLS CUI [3]
C0022661
UMLS CUI [4]
C0085605
UMLS CUI [5]
C0442874
subject with current skin diseases that the investigator feels is not safe for study participation including but not limited to severe atopic dermatitis, cutaneous t-cell lymphoma, erythroderma;
Descripción

Skin diseases

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0037274
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0036043
UMLS CUI [2,1]
C0011615
UMLS CUI [2,2]
C0205082
UMLS CUI [3]
C0079773
UMLS CUI [4]
C0598398
subjects on systemic medications known to affect the hedgehog pathway (see appendix i)
Descripción

Systemic medication affecting hedgehog pathway

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C1155468
subjects on cisapride, oral midazolam, nisoldipine, felodipine, pimozide, quinidine, dofetilide, triazolam, methadone, levacetylmethadol (levomethadyl), lovastatin, simvastatin, dihydroergotamine, ergometrine (ergonovine), ergotamine and methylergometrine (methylergonovine), cisapride, pimozide, methadone, levacetylmethadol (levomethadyl), quinidine
Descripción

Cisapride, oral midazolam, nisoldipine, felodipine, pimozide, quinidine, dofetilide, triazolam, methadone, levacetylmethadol, lovastatin, simvastatin, dihydroergotamine, ergometrine, ergotamine and methylergometrine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0072916
UMLS CUI [2,1]
C0026056
UMLS CUI [2,2]
C0442027
UMLS CUI [3]
C0028116
UMLS CUI [4]
C0015772
UMLS CUI [5]
C0031935
UMLS CUI [6]
C0034414
UMLS CUI [7]
C0114771
UMLS CUI [8]
C0040879
UMLS CUI [9]
C0025605
UMLS CUI [10]
C0772342
UMLS CUI [11]
C0024027
UMLS CUI [12]
C0074554
UMLS CUI [13]
C0012291
UMLS CUI [14]
C0014710
UMLS CUI [15]
C0025760
subjects with history of hypersensitivity to azoles
Descripción

Hypersensitivity to azoles

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0004504
subjects with gorlin syndrome
Descripción

Gorlin Syndrome

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004779
subjects on chronic immunosuppression, or who have a history of compromised immune function (e.g. history of or current malignancy other than bcc/squamous cell skin cancers)
Descripción

Chronic immunosuppression or history of compromised immune function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021079
UMLS CUI [2,1]
C4048329
UMLS CUI [2,2]
C0262926
UMLS CUI [3,1]
C0006826
UMLS CUI [3,2]
C0205394
subjects who do not speak english or have difficulty hearing or are otherwise impaired for providing informed consent and communicating with the investigator;
Descripción

Not able to speak english or hearing disorder, not able to provide informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0376245
UMLS CUI [1,2]
C1299582
UMLS CUI [2]
C1384666
UMLS CUI [3,1]
C0021430
UMLS CUI [3,2]
C1299582
UMLS CUI [4,1]
C0332268
UMLS CUI [4,2]
C2364293
UMLS CUI [4,3]
C0035173
subjects with a history of keloids or excessive scarring;
Descripción

History of keloids or excessive scarring

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0022548
UMLS CUI [1,2]
C0262926
UMLS CUI [2,1]
C0262926
UMLS CUI [2,2]
C0008767
UMLS CUI [2,3]
C0442802
subjects with known allergy to lidocaine, epinephrine, itraconazole or petrolatum
Descripción

Allergy to lidocaine, epinephrine, itraconazole or petrolatum

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0014563
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0023660
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0064113
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0031262
women of child-bearing age/potential and/or able to conceive
Descripción

Women of child-bearing age and able to conceive

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3831118
Volver a la parte superior de la página

Similar models

Eligibility Basal Cell Carcinoma NCT02120677

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
participants must be over the age of 18 years
boolean
C0001779 (UMLS CUI [1])
Male
Item
male
boolean
C1706180 (UMLS CUI [1])
Women without child-bearing potential
Item
women who do not have child-bearing potential (history of hysterectomy, post-menopausal)
boolean
C3831118 (UMLS CUI [1,1])
C0332268 (UMLS CUI [1,2])
Biopsy confirmed bcc
Item
have a biopsy confirmed bcc that measures at least 6mm in size at the time of the initial evaluation (visit #1);
boolean
C0007117 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C0449453 (UMLS CUI [2])
Protocol Compliance
Item
participant must be willing and comply with the requirements of the protocol;
boolean
C0525058 (UMLS CUI [1])
Able to understand and communicate
Item
participant must have the ability to understand and communicate with the investigator;
boolean
C2364293 (UMLS CUI [1])
C0162340 (UMLS CUI [2])
Informed consent
Item
participant must provide informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
History of Congestive heart failure, chronic renal failure, hepatic failure, neuropathy
Item
subject with significant congestive heart failure (chf) or history of chf, chronic renal failure, hepatic failure, neuropathy
boolean
C0018802 (UMLS CUI [1,1])
C0521116 (UMLS CUI [1,2])
C0018802 (UMLS CUI [2,1])
C0262926 (UMLS CUI [2,2])
C0022661 (UMLS CUI [3])
C0085605 (UMLS CUI [4])
C0442874 (UMLS CUI [5])
Skin diseases
Item
subject with current skin diseases that the investigator feels is not safe for study participation including but not limited to severe atopic dermatitis, cutaneous t-cell lymphoma, erythroderma;
boolean
C0037274 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0036043 (UMLS CUI [1,3])
C0011615 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0079773 (UMLS CUI [3])
C0598398 (UMLS CUI [4])
Systemic medication affecting hedgehog pathway
Item
subjects on systemic medications known to affect the hedgehog pathway (see appendix i)
boolean
C1515119 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C1155468 (UMLS CUI [1,3])
Cisapride, oral midazolam, nisoldipine, felodipine, pimozide, quinidine, dofetilide, triazolam, methadone, levacetylmethadol, lovastatin, simvastatin, dihydroergotamine, ergometrine, ergotamine and methylergometrine
Item
subjects on cisapride, oral midazolam, nisoldipine, felodipine, pimozide, quinidine, dofetilide, triazolam, methadone, levacetylmethadol (levomethadyl), lovastatin, simvastatin, dihydroergotamine, ergometrine (ergonovine), ergotamine and methylergometrine (methylergonovine), cisapride, pimozide, methadone, levacetylmethadol (levomethadyl), quinidine
boolean
C0072916 (UMLS CUI [1])
C0026056 (UMLS CUI [2,1])
C0442027 (UMLS CUI [2,2])
C0028116 (UMLS CUI [3])
C0015772 (UMLS CUI [4])
C0031935 (UMLS CUI [5])
C0034414 (UMLS CUI [6])
C0114771 (UMLS CUI [7])
C0040879 (UMLS CUI [8])
C0025605 (UMLS CUI [9])
C0772342 (UMLS CUI [10])
C0024027 (UMLS CUI [11])
C0074554 (UMLS CUI [12])
C0012291 (UMLS CUI [13])
C0014710 (UMLS CUI [14])
C0025760 (UMLS CUI [15])
Hypersensitivity to azoles
Item
subjects with history of hypersensitivity to azoles
boolean
C0020517 (UMLS CUI [1,1])
C0004504 (UMLS CUI [1,2])
Gorlin Syndrome
Item
subjects with gorlin syndrome
boolean
C0004779 (UMLS CUI [1])
Chronic immunosuppression or history of compromised immune function
Item
subjects on chronic immunosuppression, or who have a history of compromised immune function (e.g. history of or current malignancy other than bcc/squamous cell skin cancers)
boolean
C0021079 (UMLS CUI [1])
C4048329 (UMLS CUI [2,1])
C0262926 (UMLS CUI [2,2])
C0006826 (UMLS CUI [3,1])
C0205394 (UMLS CUI [3,2])
Not able to speak english or hearing disorder, not able to provide informed consent
Item
subjects who do not speak english or have difficulty hearing or are otherwise impaired for providing informed consent and communicating with the investigator;
boolean
C0376245 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C1384666 (UMLS CUI [2])
C0021430 (UMLS CUI [3,1])
C1299582 (UMLS CUI [3,2])
C0332268 (UMLS CUI [4,1])
C2364293 (UMLS CUI [4,2])
C0035173 (UMLS CUI [4,3])
History of keloids or excessive scarring
Item
subjects with a history of keloids or excessive scarring;
boolean
C0022548 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C0262926 (UMLS CUI [2,1])
C0008767 (UMLS CUI [2,2])
C0442802 (UMLS CUI [2,3])
Allergy to lidocaine, epinephrine, itraconazole or petrolatum
Item
subjects with known allergy to lidocaine, epinephrine, itraconazole or petrolatum
boolean
C0020517 (UMLS CUI [1,1])
C0014563 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0023660 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0064113 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0031262 (UMLS CUI [4,2])
Women of child-bearing age and able to conceive
Item
women of child-bearing age/potential and/or able to conceive
boolean
C3831118 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial